Evolus
EOLS
#7666
Rank
NZ$0.78 B
Marketcap
NZ$11.92
Share price
-6.86%
Change (1 day)
-2.30%
Change (1 year)

Earnings for Evolus (EOLS)

Earnings in 2026 (TTM): -NZ$53.38 Million

According to Evolus 's latest financial reports the company's current earnings are NZ$0.32 Billion. In 2025 the company made an earning of -NZ$93.17 Million a decrease over its 2024 earnings that were of -NZ$90.96 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Evolus from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$53.38 Million-42.71%
2025 -NZ$93.17 Million2.43%
2024 -NZ$90.96 Million-19.11%
2023 -NZ$0.12 Billion-17.23%
2022 -NZ$0.14 Billion59.02%
2021 -NZ$85.44 Million-71.32%
2020 -NZ$0.3 Billion55.09%
2019 -NZ$0.2 Billion124.48%
2018 -NZ$85.56 Million298.96%
2017 -NZ$21.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion 414.62%๐Ÿ‡บ๐Ÿ‡ธ USA